SCHEMBL8200503

SCHEMBL8200503

CN1CCc2cc(O)c(O)cc2C1CCc1ccc(Cl)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.78
TSHR P16473 1/20 0.78
MAPK1 P28482 1/20 0.78
MAOA P21397 2/20 0.71
NR1I2 O75469 1/20 0.71
PTGS2 P35354 1/20 0.71
OPRK1 P41145 1/20 0.71
SLC6A3 Q01959 1/20 0.71
DRD2 P14416 4/20 0.62
DRD4 P21917 1/20 0.62
DRD1 P21728 2/20 0.54
DRD3 P35462 1/20 0.51
GRIN2D O15399 4/20 0.47
GRIN3B O60391 4/20 0.47
GRIN1 Q05586 4/20 0.47
GRIN2A Q12879 4/20 0.47
GRIN2B Q13224 4/20 0.47
GRIN2C Q14957 4/20 0.47
GRIN3A Q8TCU5 4/20 0.47
KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5908036 0.89 TP53 (0.98) TP53TSHRMAPK1MAOANR1I2
SCHEMBL29651290 0.89 TP53 (0.98) TP53TSHRMAPK1MAOANR1I2
Hydrochloric Acid SCHEMBL2000082 0.88 TP53 (1.00) TP53TSHRMAPK1MAOANR1I2
Methopholine SCHEMBL30492235 0.83 NR1I2 (1.00) TP53TSHRMAPK1MAOANR1I2
Methopholine SCHEMBL26169 0.83 NR1I2 (1.00) TP53TSHRMAPK1MAOANR1I2
SCHEMBL3991605 0.77 TSHR (0.50) TP53TSHRMAPK1MAOANR1I2
SCHEMBL13356020 0.76 DRD2 (1.00) MAPK1DRD2DRD4DRD1DRD3
SCHEMBL29617590 0.76 DRD2 (1.00) MAPK1DRD2DRD4DRD1DRD3
SCHEMBL20683170 0.76 DRD2 (0.79) TP53TSHRMAPK1MAOANR1I2
SCHEMBL12633796 0.75 DRD2 (0.65) MAOADRD2DRD4DRD1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952344-A TREATING AND CONTROL OF DISEASES WHICH REPRESENT THERAPEUTIC INDICATIONS FOR NMDA(N-METHYL-D-ASPERTATE) RECEPTOR SUBTYPE SPECIFIC BLOKERS BY ADMINISTERING TETRAHYDROISOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 1999-09-14 US claimed
EP-0787493-A1 Tetrahydroisoquinoline derivatives F. HOFFMANN-LA ROCHE AG (CH) 1997-08-06 EP claimed
US-6071929-A SELECTIVE BLOCKERS OF N-METHYL-D-ASPARTIC ACID FOR TEATMENT OF NERVOUS SYSTEM AND BRAIN DISORDERS OR INJURIES HOFFMAN-LA ROCHE INC. (US) 2000-06-06 US disclosed
US-5952344-A TREATING AND CONTROL OF DISEASES WHICH REPRESENT THERAPEUTIC INDICATIONS FOR NMDA(N-METHYL-D-ASPERTATE) RECEPTOR SUBTYPE SPECIFIC BLOKERS BY ADMINISTERING TETRAHYDROISOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 1999-09-14 US disclosed
EP-0787493-A1 Tetrahydroisoquinoline derivatives F. HOFFMANN-LA ROCHE AG (CH) 1997-08-06 EP disclosed